Clinica Las Condes S.A.

As of June 30, 2026, Clinica Las Condes S.A. has 15.79M shares outstanding.

As of June 30, 2026, Clinica Las Condes S.A. maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 106.72, indicating elevated leverage, while an interest coverage ratio of -3.05 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Clinica Las Condes S.A. posted a negative return on equity (ROE) of -19.51, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.09, reflecting losses generated across the asset base. The company generates approximately 79,984.73 in revenue per employee across its workforce of 2,505.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 49.45 indicates how many times Clinica Las Condes S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Clinica Las Condes S.A. recorded an income tax benefit of -17.36M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -67.37M and -47.46M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Clinica Las Condes S.A. generated 200.38M in revenue and converted that into -47.46M in net income, yielding earnings per share of -2.81. EBITDA reached -27.52M, while operating income came in at -36.95M.

As of June 30, 2026, Clinica Las Condes S.A. holds 42.36M in cash and equivalents against 290.96M in total debt, resulting in a net debt position of 269.79M. Total book value stands at 275.15M, with working capital of 141,318.33 providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Clinica Las Condes S.A. posted a gross margin of 18.99, reflecting its pricing power and cost economics. The operating margin of -18.44 and net profit margin of -23.68 provide insight into operational efficiency.

Clinica Las Condes S.A.'s most recent stock split took place on June 17, 2026.